Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Ingredion Incorporated. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Ingredion Incorporated (INGR) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Ingredion Incorporated (NYSE: INGR).
On November 5, 2026, Ingredion announced its third-quarter financial results, reporting adjusted earnings per share of $2.28, a decline of approximately 17% from $2.75 in the prior-year quarter. The Company attributed the decline in part to higher manufacturing costs and lowered its full-year earnings outlook. Following this news, Ingredion’s stock opened approximately 5% lower on November 5, before recovering to close slightly higher that day. As of 10:05 a.m. Eastern on November 11, 2026, Ingredion shares were trading at $91.76, down $0.19 per share, or 0.21%, for the day.
What Potential Securities Violations Is BG&G Investigating?
- Whether Ingredion Incorporated and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Ingredion Incorporated failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Ingredion Incorporated (INGR) Investors Do?
How Is Ingredion Incorporated (NYSE: INGR) Stock Trading Today?
Interactive chart showing the weekly share price history of NYSE:INGR (NYSE:INGR).
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”